An uncontrolled long-term safety study of Diclofenac Sodium gel 1% in patients with osteoarthritis of the knee.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions
- Sponsors Novartis
- 20 Apr 2012 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
- 20 Apr 2012 Actual initiation date (Oct 2004) added as reported by ClinicalTrials.gov.
- 24 Oct 2009 New trial record